|Day Low/High||99.17 / 100.90|
|52 Wk Low/High||75.20 / 107.08|
Patient treated at cancer care center in Italy
Two highest scoring plans and 7 of the top 10 at the 2017 International Radiotherapy Plan Competition used Eclipse treatment planning software
New system now has 510(k) clearance and CE mark
Researchers to highlight advances in radiosurgery at International Stereotactic Radiosurgery Society (ISRS)
Advanced proton therapy systems from Varian now available to cancer centers in Japan
Unveiled on show floor, Halcyon simplifies and enhances image-guided volumetric IMRT
Halcyon human-centered design revolutionizes clinical workflow; simplifies and enhances image-guided volumetric IMRT
Even though it has $1.5 billion of M&A capacity, PerkinElmer is unlikely to pursue a large bolt-on deal, according to Cantor Fitzgerald analyst Bryan Brokmeier.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ARES, ASH, AXTA, BLMN, CNTY, EVK, HCOM, JWN, OB, RUSHB, SEDG, SUN, VAR, WES Downgrades: CYBE, KIM Initiations: WBT Read on to get TheStreet Quant Ratings' detailed report:
In trading on Monday, shares of Varian Medical Systems Inc crossed below their 200 day moving average of $90.37, changing hands as low as $90.18 per share. Varian Medical Systems Inc shares are currently trading down about 0.3% on the day.
Gary E. Bischoping, Jr. of Dell Technologies named to replace the retiring Elisha Finney